FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/02/080391 [Registered on: 12/02/2025] Trial Registered Prospectively
Last Modified On: 10/02/2025
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Single Arm Study 
Public Title of Study   How bone fractures vary by age and body location: A study of bone structure  
Scientific Title of Study   Fracture patterns in different anatomical locations and age demographics: A Cross-sectional Analysis of Microscopic Anatomy. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
Nil  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Sundip Charmode 
Designation  Associate Professor 
Affiliation  All-India Institute of Medical Sciences Rajkot 
Address  Department of Anatomy, Academic block, AIIMS Rajkot, KHANDHERI, RAJKOT-360110

Rajkot
GUJARAT
360110
India 
Phone  09633239685  
Fax    
Email  sundip.charmode@yahoo.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sundip Charmode 
Designation  Associate Professor 
Affiliation  All-India Institute of Medical Sciences Rajkot 
Address  Department of Anatomy, Ground floor, Academic block, AIIMS Rajkot, KHANDHERI, RAJKOT-360110

Rajkot
GUJARAT
360110
India 
Phone  09633239685  
Fax    
Email  sundip.charmode@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Dr Sundip Charmode 
Designation  Associate Professor 
Affiliation  All-India Institute of Medical Sciences Rajkot 
Address  Department of Anatomy, Ground floor, Academic block, AIIMS Rajkot, KHANDHERI, RAJKOT-360110

Rajkot
GUJARAT
360110
India 
Phone  09633239685  
Fax    
Email  sundip.charmode@yahoo.com  
 
Source of Monetary or Material Support  
Department of Anatomy, and Orthopedics, All India Institute of medical Sciences (AIIMS) Rajkot, Gujarat-360110 
 
Primary Sponsor  
Name  Dr Sundip Charmode 
Address  Department of Anatomy, Academic block, AIIMS Rajkot, KHANDHERI, RAJKOT-360110 
Type of Sponsor  Other [All the expenses arising from this project study will be paid from my Learning resource allowance. ] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sundip Charmode  All India Institute of Medical Sciences (AIIMS) Rajkot  Department of Anatomy, Academic block, AIIMS Rajkot, KHANDHERI, RAJKOT-360110
Rajkot
GUJARAT 
09633239685

sundip.charmode@yahoo.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical committee, AIIMS Rajkot  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M849||Disorder of continuity of bone, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Microscopic analysis of bone callus   The samples of bone callus shall be collected and processed and stained using standard histological methods in the histology laboratory of anatomy department by the principal investigator. The trabecular thickness, percentage value of cartilage, fibrous tissue and osseous tissue in callus shall be determined using Image J software. The stained specimens will be photographed using the trinocular microscope (with attached camera) and computer system. The duration of time required for the intervention shall be 7 days for every sample of callus. The collected samples will be processed in this time duration of 7 days (maximum limit) and the results will be conveyed to the orthopedic surgeon for doing the required modification in the treatment and follow up care of the said patient.  
Comparator Agent  NIL  NIL 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  75.00 Year(s)
Gender  Both 
Details  1. Patients aged 18 years and above.
2. Any bone fractures treated with any modality of open reduction and internal fixation with any type of fixation device.
3. Secondary surgeries for internal fixation failures or hypertrophic nonunion.

 
 
ExclusionCriteria 
Details  1. Patients under 18 years.
2. Fractures with infection, brain injury, bone tumors, systemic diseases, or those treated with hormones, steroids, vitamin D, or calcium.
 
 
Method of Generating Random Sequence   Stratified randomization 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
The primary outcome of the study is to study the fracture patterns in different anatomical locations at microscopic level in patients reporting to orthopedic OPD.



 
This is a cross-sectional study, so all the 50 study participants/patients and their respective callus samples shall be assessed for all the variables/parameters [Anthropometric and Microscopic] only at the time of their reporting to the OPD/IPD i.e. at the baseline.

No follow-up is going to be done in this study.

 
 
Secondary Outcome  
Outcome  TimePoints 
The secondary outcomes of this project study is as follows:
1. To study the fractures patterns in patients reporting at varying periods of time to the orthopedic OPD.
2. To study the fractures patterns in different age groups in patients reporting to orthopedic OPD.
 
For the above-mentioned secondary outcomes of this project study, all the patients & their callus samples will be assessed for the variables/parameters [anthropometric & microscopic] only at the time of their reporting to the OPD/IPD, i.e. at the baseline.

No follow up shall be done in this study. 
 
Target Sample Size   Total Sample Size="50"
Sample Size from India="50" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/03/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Informed Consent Form
    Response - Clinical Study Report
    Response -  Analytic Code

  3. Who will be able to view these files?
    Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.

  4. For what types of analyses will this data be available?
    Response - To achieve aims in the approved proposal.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [sundip.charmode@yahoo.com].

  6. For how long will this data be available start date provided 01-01-2027 and end date provided 31-12-2027?
    Response - Immediately following publication. No end date.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary  

Till now it was thought that the bone repair and regeneration is controlled by the bone turnover process which is an interplay of bone cells (osteoblasts, osteoclasts and osteocytes), and osteo-inductive growth factors, but recently published review articles observed a major role of immune cells and pro-inflammatory cytokines behind it. These articles also say that the presence of an appropriate immune microenvironment is very important to create an acute inflammatory response which is essential for onset of bone repair and also for late bone remodeling. The bone callus is known to be histologically compatible and non-immunogenic and has osteogenic potential to be used as a graft, but very few studies have practically proven this in humans. These review articles have found that the reason behind slow bone repair and regeneration in elderly is the secretion of senescent markers by the older osteoblasts and osteoclasts, but human studies are required to prove their underlying mechanism. Thus, there is an urgent need to do human research studies to see the structure and function of bone callus with respect to its cellular composition, presence of osteo-inductive growth factors, and the existence of immune micro-environment using histological, immunohistochemistry analyses. No studies have examined the bone callus structure in different age groups, fracture locations and post-fracture times, creating to the need of our study.

The patients with fractures coming to orthopedic OPD, who will fulfil the eligibility criteria will be selected if they give written consent to participate in this project. General information of the patient and the medical/surgical history will be taken using a case record form. The bone callus samples will be collected from the patient during the operation by the orthopedic surgeon who is the co-investigator. The specimen shall be sent to histology laboratory of anatomy department to the principal investigator for staining using the standard histological methods. The stained specimens will be photographed using the trinocular microscope with attached camera and recorded by the principal investigator.      The quantitative data will be compiled in a master chart, tabulated and graphically represented. Later statistical analysis of the data will be done based on the various age groups, fracture sites and fracture period times and conclusions will be derived.

 


 
Close